Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. CDN Services

We are analyzing https://link.springer.com/article/10.1007/s10549-016-4059-6.

Title:
Triple-negative breast cancer has worse overall survival and cause-specific survival than non-triple-negative breast cancer | Breast Cancer Research and Treatment
Description:
Purpose The current American Joint Committee on Cancer (AJCC) staging manual uses tumor size, lymph node, and metastatic status to stage breast cancer across different subtypes. We examined the prognosis of triple-negative breast cancer (TNBC) versus non-TNBC within the same stages and sub-stages to evaluate whether TNBC had worse prognosis than non-TNBC. Methods We reviewed the National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) data and identified 158,358 patients diagnosed with breast cancer from 2010 to 2012. The overall survival (OS) time and breast cancer cause-specific survival time were compared between patients with TNBC and non-TNBC in each stage and sub-stages. The results were validated using a dataset of 2049 patients with longer follow-up from our institution. Results Compared with patients with non-TNBC, patients with TNBC had worse OS and breast cancer cause-specific survival time in every stage and sub-stage in univariate and multivariate analyses adjusting for age, race, tumor grade, and surgery and radiation treatments in the SEER data. The worse OS time in patients with TNBC was validated in our institutional dataset. Conclusions Patients with TNBC have worse survival than patients with non-TNBC. The new AJCC staging manual should consider breast cancer biomarker information.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {๐Ÿ“š}

  • Health & Fitness
  • Education
  • Science

Content Management System {๐Ÿ“}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {๐Ÿ“ˆ}

What is the average monthly size of link.springer.com audience?

๐ŸŒ  Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 8,170,236 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {๐Ÿ’ธ}

We're unsure how the site profits.

Not all websites are made for profit; some exist to inform or educate users. Or any other reason why people make websites. And this might be the case. Link.springer.com might be cashing in, but we can't detect the method they're using.

Keywords {๐Ÿ”}

cancer, breast, article, pubmed, google, scholar, survival, triplenegative, cas, patients, central, clin, tnbc, staging, usa, data, worse, oncol, content, stage, nontnbc, center, authors, department, university, privacy, cookies, research, causespecific, joint, institute, time, cancers, chemotherapy, analysis, information, publish, search, november, yang, peng, sahin, american, committee, ajcc, prognosis, compared, access, res, springer,

Topics {โœ’๏ธ}

month download article/chapter brca1-positive breast cancers triple-negative breast cancers disease-free survival predicting disease-specific survival triple-negative breast cancer triple-negative breast cancer stromal pd-l1 expression patient-level meta-analysis residual breast cancers subtype breast cancers full article pdf cancer staging system privacy choices/manage cookies breast cancer treated ajcc staging manual stage breast cancer mittendorf ea winship cancer institute american joint committee differentiate breast carcinoma edge sb molecular heterogeneity article li electronic supplementary material li xb androgen receptor planned joint analysis european economic area multivariate analyses adjusting related subjects geyer ce jr specific survival time conditions privacy policy reis-filho js breast cancer article log accepting optional cookies gonzalez-angulo ethics declarations conflict worse prognosis author information authors staging manual xiaoxian li stage ib designation article cite tumor-initiating features journal finder publish staging system specific survival

Questions {โ“}

  • Outcomes of Triple-Negative Breast Cancers (TNBC) Compared with Non-TNBC: Does the Survival Vary for All Stages?

Schema {๐Ÿ—บ๏ธ}

WebPage:
      mainEntity:
         headline:Triple-negative breast cancer has worse overall survival and cause-specific survival than non-triple-negative breast cancer
         description:The current American Joint Committee on Cancer (AJCC) staging manual uses tumor size, lymph node, and metastatic status to stage breast cancer across different subtypes. We examined the prognosis of triple-negative breast cancer (TNBC) versus non-TNBC within the same stages and sub-stages to evaluate whether TNBC had worse prognosis than non-TNBC. We reviewed the National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) data and identified 158,358 patients diagnosed with breast cancer from 2010 to 2012. The overall survival (OS) time and breast cancer cause-specific survival time were compared between patients with TNBC and non-TNBC in each stage and sub-stages. The results were validated using a dataset of 2049 patients with longer follow-up from our institution. Compared with patients with non-TNBC, patients with TNBC had worse OS and breast cancer cause-specific survival time in every stage and sub-stage in univariate and multivariate analyses adjusting for age, race, tumor grade, and surgery and radiation treatments in the SEER data. The worse OS time in patients with TNBC was validated in our institutional dataset. Patients with TNBC have worse survival than patients with non-TNBC. The new AJCC staging manual should consider breast cancer biomarker information.
         datePublished:2016-11-25T00:00:00Z
         dateModified:2016-11-25T00:00:00Z
         pageStart:279
         pageEnd:287
         sameAs:https://doi.org/10.1007/s10549-016-4059-6
         keywords:
            Triple-negative breast cancer
            TNBC
            Prognosis
            Overall survival
            Cause-specific survival
            AJCC
            Cancer staging
            Oncology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-016-4059-6/MediaObjects/10549_2016_4059_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-016-4059-6/MediaObjects/10549_2016_4059_Fig2_HTML.gif
         isPartOf:
            name:Breast Cancer Research and Treatment
            issn:
               1573-7217
               0167-6806
            volumeNumber:161
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer US
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Xiaoxian Li
               url:http://orcid.org/0000-0002-0995-1721
               affiliation:
                     name:Emory University
                     address:
                        name:Department of Pathology and Laboratory Medicine, Glenn Family Breast Center, Winship Cancer Institute, Emory University, Atlanta, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Jing Yang
               affiliation:
                     name:Emory University
                     address:
                        name:Department of Biostatistics and Bioinformatics, Emory University, Atlanta, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Limin Peng
               affiliation:
                     name:Emory University
                     address:
                        name:Department of Biostatistics and Bioinformatics, Emory University, Atlanta, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Aysegul A. Sahin
               affiliation:
                     name:The University of Texas MD Anderson Cancer Center
                     address:
                        name:Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Lei Huo
               affiliation:
                     name:The University of Texas MD Anderson Cancer Center
                     address:
                        name:Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Kevin C. Ward
               affiliation:
                     name:Emory University
                     address:
                        name:Department of Biostatistics and Bioinformatics, Emory University, Atlanta, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Ruth Oโ€™Regan
               affiliation:
                     name:University of Wisconsin
                     address:
                        name:Department of Medicine, University of Wisconsin, Madison, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Mylin A. Torres
               affiliation:
                     name:Emory University
                     address:
                        name:Department of Radiation Oncology, Glenn Family Breast Center, Winship Cancer Institute, Emory University, Atlanta, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Jane L. Meisel
               affiliation:
                     name:Emory University
                     address:
                        name:Department of Hematology and Medical Oncology, Glenn Family Breast Center, Winship Cancer Institute, Emory University, Atlanta, USA
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Triple-negative breast cancer has worse overall survival and cause-specific survival than non-triple-negative breast cancer
      description:The current American Joint Committee on Cancer (AJCC) staging manual uses tumor size, lymph node, and metastatic status to stage breast cancer across different subtypes. We examined the prognosis of triple-negative breast cancer (TNBC) versus non-TNBC within the same stages and sub-stages to evaluate whether TNBC had worse prognosis than non-TNBC. We reviewed the National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) data and identified 158,358 patients diagnosed with breast cancer from 2010 to 2012. The overall survival (OS) time and breast cancer cause-specific survival time were compared between patients with TNBC and non-TNBC in each stage and sub-stages. The results were validated using a dataset of 2049 patients with longer follow-up from our institution. Compared with patients with non-TNBC, patients with TNBC had worse OS and breast cancer cause-specific survival time in every stage and sub-stage in univariate and multivariate analyses adjusting for age, race, tumor grade, and surgery and radiation treatments in the SEER data. The worse OS time in patients with TNBC was validated in our institutional dataset. Patients with TNBC have worse survival than patients with non-TNBC. The new AJCC staging manual should consider breast cancer biomarker information.
      datePublished:2016-11-25T00:00:00Z
      dateModified:2016-11-25T00:00:00Z
      pageStart:279
      pageEnd:287
      sameAs:https://doi.org/10.1007/s10549-016-4059-6
      keywords:
         Triple-negative breast cancer
         TNBC
         Prognosis
         Overall survival
         Cause-specific survival
         AJCC
         Cancer staging
         Oncology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-016-4059-6/MediaObjects/10549_2016_4059_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-016-4059-6/MediaObjects/10549_2016_4059_Fig2_HTML.gif
      isPartOf:
         name:Breast Cancer Research and Treatment
         issn:
            1573-7217
            0167-6806
         volumeNumber:161
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer US
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Xiaoxian Li
            url:http://orcid.org/0000-0002-0995-1721
            affiliation:
                  name:Emory University
                  address:
                     name:Department of Pathology and Laboratory Medicine, Glenn Family Breast Center, Winship Cancer Institute, Emory University, Atlanta, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Jing Yang
            affiliation:
                  name:Emory University
                  address:
                     name:Department of Biostatistics and Bioinformatics, Emory University, Atlanta, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Limin Peng
            affiliation:
                  name:Emory University
                  address:
                     name:Department of Biostatistics and Bioinformatics, Emory University, Atlanta, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Aysegul A. Sahin
            affiliation:
                  name:The University of Texas MD Anderson Cancer Center
                  address:
                     name:Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Lei Huo
            affiliation:
                  name:The University of Texas MD Anderson Cancer Center
                  address:
                     name:Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Kevin C. Ward
            affiliation:
                  name:Emory University
                  address:
                     name:Department of Biostatistics and Bioinformatics, Emory University, Atlanta, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Ruth Oโ€™Regan
            affiliation:
                  name:University of Wisconsin
                  address:
                     name:Department of Medicine, University of Wisconsin, Madison, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Mylin A. Torres
            affiliation:
                  name:Emory University
                  address:
                     name:Department of Radiation Oncology, Glenn Family Breast Center, Winship Cancer Institute, Emory University, Atlanta, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Jane L. Meisel
            affiliation:
                  name:Emory University
                  address:
                     name:Department of Hematology and Medical Oncology, Glenn Family Breast Center, Winship Cancer Institute, Emory University, Atlanta, USA
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Breast Cancer Research and Treatment
      issn:
         1573-7217
         0167-6806
      volumeNumber:161
Organization:
      name:Springer US
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Emory University
      address:
         name:Department of Pathology and Laboratory Medicine, Glenn Family Breast Center, Winship Cancer Institute, Emory University, Atlanta, USA
         type:PostalAddress
      name:Emory University
      address:
         name:Department of Biostatistics and Bioinformatics, Emory University, Atlanta, USA
         type:PostalAddress
      name:Emory University
      address:
         name:Department of Biostatistics and Bioinformatics, Emory University, Atlanta, USA
         type:PostalAddress
      name:The University of Texas MD Anderson Cancer Center
      address:
         name:Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, USA
         type:PostalAddress
      name:The University of Texas MD Anderson Cancer Center
      address:
         name:Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, USA
         type:PostalAddress
      name:Emory University
      address:
         name:Department of Biostatistics and Bioinformatics, Emory University, Atlanta, USA
         type:PostalAddress
      name:University of Wisconsin
      address:
         name:Department of Medicine, University of Wisconsin, Madison, USA
         type:PostalAddress
      name:Emory University
      address:
         name:Department of Radiation Oncology, Glenn Family Breast Center, Winship Cancer Institute, Emory University, Atlanta, USA
         type:PostalAddress
      name:Emory University
      address:
         name:Department of Hematology and Medical Oncology, Glenn Family Breast Center, Winship Cancer Institute, Emory University, Atlanta, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Xiaoxian Li
      url:http://orcid.org/0000-0002-0995-1721
      affiliation:
            name:Emory University
            address:
               name:Department of Pathology and Laboratory Medicine, Glenn Family Breast Center, Winship Cancer Institute, Emory University, Atlanta, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Jing Yang
      affiliation:
            name:Emory University
            address:
               name:Department of Biostatistics and Bioinformatics, Emory University, Atlanta, USA
               type:PostalAddress
            type:Organization
      name:Limin Peng
      affiliation:
            name:Emory University
            address:
               name:Department of Biostatistics and Bioinformatics, Emory University, Atlanta, USA
               type:PostalAddress
            type:Organization
      name:Aysegul A. Sahin
      affiliation:
            name:The University of Texas MD Anderson Cancer Center
            address:
               name:Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, USA
               type:PostalAddress
            type:Organization
      name:Lei Huo
      affiliation:
            name:The University of Texas MD Anderson Cancer Center
            address:
               name:Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, USA
               type:PostalAddress
            type:Organization
      name:Kevin C. Ward
      affiliation:
            name:Emory University
            address:
               name:Department of Biostatistics and Bioinformatics, Emory University, Atlanta, USA
               type:PostalAddress
            type:Organization
      name:Ruth Oโ€™Regan
      affiliation:
            name:University of Wisconsin
            address:
               name:Department of Medicine, University of Wisconsin, Madison, USA
               type:PostalAddress
            type:Organization
      name:Mylin A. Torres
      affiliation:
            name:Emory University
            address:
               name:Department of Radiation Oncology, Glenn Family Breast Center, Winship Cancer Institute, Emory University, Atlanta, USA
               type:PostalAddress
            type:Organization
      name:Jane L. Meisel
      affiliation:
            name:Emory University
            address:
               name:Department of Hematology and Medical Oncology, Glenn Family Breast Center, Winship Cancer Institute, Emory University, Atlanta, USA
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Department of Pathology and Laboratory Medicine, Glenn Family Breast Center, Winship Cancer Institute, Emory University, Atlanta, USA
      name:Department of Biostatistics and Bioinformatics, Emory University, Atlanta, USA
      name:Department of Biostatistics and Bioinformatics, Emory University, Atlanta, USA
      name:Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, USA
      name:Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, USA
      name:Department of Biostatistics and Bioinformatics, Emory University, Atlanta, USA
      name:Department of Medicine, University of Wisconsin, Madison, USA
      name:Department of Radiation Oncology, Glenn Family Breast Center, Winship Cancer Institute, Emory University, Atlanta, USA
      name:Department of Hematology and Medical Oncology, Glenn Family Breast Center, Winship Cancer Institute, Emory University, Atlanta, USA
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {๐Ÿ”—}(124)

Analytics and Tracking {๐Ÿ“Š}

  • Google Tag Manager

Libraries {๐Ÿ“š}

  • Clipboard.js
  • Prism.js

CDN Services {๐Ÿ“ฆ}

  • Crossref

4.03s.